絞り込み

16646

広告

Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.

著者 Feng W , Wu K , Liu Z , Kong G , Deng Z , Chen S , Wu Y , Chen M , Liu S , Wang H
Thromb Res.2015 Oct 20 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (324view , 0users)

Full Text Sources

Medical

To analyze the efficacy and safety of direct factor Xa inhibitors for thromboprophylaxis after total hip or knee replacement. To delineate the dose response effect of direct factor Xa inhibitors. To compare the efficacy between any two direct factor Xa inhibitors.
PMID: 26498222 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード